首页> 外国专利> Nucleic acid molecules encoding combinatorial gamma 9 delta 2 T-cell receptors and methods of use thereof to treat cancer

Nucleic acid molecules encoding combinatorial gamma 9 delta 2 T-cell receptors and methods of use thereof to treat cancer

机译:编码组合γ9 delta 2 T细胞受体的核酸分子及其用于治疗癌症的方法

摘要

The current invention provides methods to identify γ9δ2T-cell receptors (γ9δ2TCR) that mediate anti-tumour responses. Surprisingly, it was now found that the CDR3 regions of the γ9-T-cell receptor chain and the δ2-T-Cell receptor chain (δ2TCR chain) are of importance. Based on these findings, combinatorial-γδTCR-chain-exchange (CTE) is proposed as an efficient method for identifying γ9δ2TCRs that mediate anti-tumour responses. Using the method of the invention, specific sequences of the respective γ9TCR and δ2TCR chains were identified that mediate anti-tumour responses. Hence, the invention further provides for specific γ9δ2TCRs, or fragments thereof, that may be used e.g. in diagnostics or treatment of cancer. The invention further provides for nucleic acid sequences, genetic constructs and retroviral vectors that can be used to express the γ9δ2TCRs according to the invention.
机译:本发明提供了鉴定介导抗肿瘤反应的γ9δ2T细胞受体(γ9δ2TCR)的方法。令人惊讶地,现在发现γ9-T细胞受体链和δ2-T细胞受体链(δ2TCR链)的CDR3区域是重要的。基于这些发现,提出组合γδTCR链交换(CTE)作为鉴定介导抗肿瘤反应的γ9δ2TCR的有效方法。使用本发明的方法,鉴定了分别介导抗肿瘤应答的γ9TCR和δ2TCR链的特定序列。因此,本发明进一步提供了特定的γ9δ2TCR或其片段,其可以例如被使用。诊断或治疗癌症。本发明进一步提供了可用于表达根据本发明的γ9δ2TCR的核酸序列,遗传构建体和逆转录病毒载体。

著录项

  • 公开/公告号US10578609B2

    专利类型

  • 公开/公告日2020-03-03

    原文格式PDF

  • 申请/专利权人 GADETA B.V.;

    申请/专利号US201615374613

  • 申请日2016-12-09

  • 分类号C07K14/705;A61K38;G01N33/50;A61K35/17;C07K14/725;C12N15/85;G01N33/68;C12N5/0783;

  • 国家 US

  • 入库时间 2022-08-21 11:27:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号